The companies pledge to only submit their vaccine for approval or emergency use authorization after phase three of a clinical trial.
The companies pledge to only submit their vaccine for approval or emergency use authorization after phase three of a clinical trial.
Results from an early safety study of Moderna's coronavirus vaccine candidate in older adults showed that it produced..
Biopharmaceutical giants Moderna and Regeneron lead other biotech companies higher after they each announce positive Covid-19..